Concepedia
Statistics
Publications
11
Citations
1.4K
H-Index
Active since
2006
Affiliations
Amgen (United States)(Current)
National Cancer Institute
Jan Sun is an author at Amgen (United States) specializing in oncology, molecular oncology, and life sciences.
Publications per year
2006–2023
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 419 citations · Full text
Medicine, Oncology, Pharmacology +14
Fully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential against Hepatocyte Growth Factor/c-Met–Dependent Human Tumors
Teresa L. Burgess, Angela Coxon, Susanne Meyer et al. · Cancer Research · 2006 · 253 citations
Life Sciences, Oncology, Pharmacology +17
Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy
Hanqiu Zheng, Yangjin Bae, Sabine Kasimir‐Bauer et al. · Cancer Cell · 2017 · 158 citations · Full text
Medicine, Oncology, Pharmacology +12
AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts
H. Toni Jun, Jan Sun, Karen Rex et al. · Clinical Cancer Research · 2007 · 145 citations
Medicine, Oncology, Pharmacology +15
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension
Swati Dabral, Tian Xia, Baktybek Kojonazarov et al. · European Respiratory Journal · 2016 · 119 citations · Full text
Life Sciences, Cardiology, Cell Biology +15
1–5 of 11